Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Australian Frailty Network: Development of a consumer-focussed national response to frailty.
Reid N, Young A, Baldassar L, Christoffersen A, Comans T, Conroy S, Etherton-Beer C, Ferris J, Singh MF, Fox S, Gordon EH, Ghosh M, Guha C, Hilmer S, Kouladjian O'Donnell L, Logan B, Ludlow K, Miller M, Morgan M, Mudge A, Muscedere J, Reidlinger D, Rockwood K, Saunders R, Ward D, Yates P, Hubbard RE. Reid N, et al. Among authors: etherton beer c. Australas J Ageing. 2024 Dec;43(4):852-860. doi: 10.1111/ajag.13365. Epub 2024 Sep 29. Australas J Ageing. 2024. PMID: 39342487 Free PMC article.
Community-based dementia risk management and prevention program for Aboriginal Australians (DAMPAA): a randomised controlled trial study protocol.
Lalovic A, Dowden G, Markey L, Bynder M, Yappo L, Cox KL, Mateo-Arriero I, Flicker L, Bessarab D, Thompson S, Kickett C, Woods D, Pestell CF, Edgill P, Hill K, Etherton-Beer C, LoGiudice D, Almeida OP, Lin I, Milte R, Ratcliffe J, Hyde Z, Smith K. Lalovic A, et al. Among authors: etherton beer c. BMJ Open. 2024 Sep 13;14(9):e088281. doi: 10.1136/bmjopen-2024-088281. BMJ Open. 2024. PMID: 39277208 Free PMC article.
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study.
Lopez D, Pritchard D, Sanfilippo FM, Kelty E, Page A, Etherton-Beer C, Almeida OP, Preen DB. Lopez D, et al. Among authors: etherton beer c. Infect Dis Now. 2024 Sep;54(6):104953. doi: 10.1016/j.idnow.2024.104953. Epub 2024 Jul 2. Infect Dis Now. 2024. PMID: 38964717 Free article.
158 results